CPMG Inc, Director, 10% Owner at REATA PHARMACEUTICALS INC (RETA), bought 141,560 shares at $17.26 ($2.4M) on 2016-08-17, disclosed to the SEC on 2016-08-18.
Open-market purchase of $2.4M RETA by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.26 | 5,830 | $101K | 4.1% |
| 2 | $17.26 | 8,820 | $152K | 6.2% |
| 3 | $17.26 | 32,080 | $554K | 22.7% |
| 4 | $17.26 | 46,510 | $803K | 32.9% |
| 5 | $17.26 | 48,320 | $834K | 34.1% |
| Total | $17.26 avg | 141,560 |
| $2.4M |
| 100% |
| Filing → |
| RETA | BUY | 2019-11-18 | $7.4M | — | Filing → |
| RETA | BUY | 2018-12-12 | $13.2M | — | Filing → |
| RETA | BUY | 2017-12-29 | $484K | — | Filing → |